Although the mechanisms underpinning a role for SRC in PDAC chemo-resistance are still unclear, these findings support the use of SRC inhibitors as a complementary strategy to improve response of pancreatic tumors to chemotherapy. Here, SRC is linked to pancreatic neoplasm.